1. All Products
  2. DINJVERA - Verapamil
  3. VERAPAMIL hydrochloride, 2.5mg/ml, 2ml, amp.
Liste de prix publique

VERAPAMIL hydrochloride, 2.5mg/ml, 2ml, amp.

https://unicat.msf.org/cat/product/11819
STD DINJVERA2A-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
12.2 - Antiarrhythmic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C08DA01
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://www.unicat.msf.org/web/image/product.template/572746/image_1920?unique=fe3a5ca

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

VERAPAMIL

Therapeutic Action

Calcium-channel blocker

Indications

  • Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias (SVT)
  • Temporary control of rapid ventricular rate in atrial fibrillation or flutter

Instructions for use

Must be given as slow IV injection.

Posology:

  • 2.5-5 mg direct IV over 2 minutes
  • If needed, administer 5-10 mg after 15-30 minutes
  • Maximum total dose: 30 mg

Administer only in hospital settings with monitoring and cardiorespiratory resuscitation equipment available for immediate use.

During administration, continuous ECG monitoring is necessary due to the risk of fatal arrhythmias.

Diltiazem can be used as an alternative in case of supply issues.

Contact your OC anaesthetist advisor for more details.

Precautions for Use

Contraindicated in patients with:

  • Cardiogenic shock
  • Decompensated heart failure or severe left ventricular dysfunction
  • Symptomatic hypotension (SBP < 90mmHg)
  • Sick sinus syndrome (unless permanent pacemaker in place)
  • Wide-complex tachycardia
  • 2nd/3rd degree AV block (unless permanent pacemaker in place)
  • Atrial flutter/fibrillation combined with Wolff-Parkinson-White syndrome

Do not combine with beta‑blockers due to risk of severe bradycardia or heart block.

Storage

Below 25°C - Protect from sunlight